Goldman Sachs keeps a Buy rating with an HK$18.88 price target on China Medical System, which is being added to the firm’s new “APAC Conviction List – Directors’ Cut.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CHSYF: